Synergistic cytotoxic effects of recombinant human adenovirus p53 and radiation at various time points in A549 lung adenocarcinoma cells

Oncology Letters

Volumn 4, Issue 3, 2012, Pages 529-533

  Ma, Jie Tao ^a   Han, Cheng Bo ^a   Zhao, Jian Zhu ^a   Jing, Wei ^a   Zhou, Yang ^a   Huang, Le Tian ^a   Zou, Hua Wei ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Adenovirus p53; Gene therapy; Radiation therapy

Indexed keywords

ADENOVIRUS VECTOR; GENDICINE; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER RADIOTHERAPY; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENTIATION; FLOW CYTOMETRY; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; MULTIMODALITY CANCER THERAPY; PROTEIN EXPRESSION; RADIATION DOSE; TIME; TREATMENT RESPONSE; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING;

EID: 84863871929     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.747     Document Type: Article

References (18)

1. Vousden KH and Lu X: Live or let die: the cell's response to p53. Nat Rev Cancer 2: 594-604, 2002.
2. Hirao A, Kong YY, Matsuoka S, Wakeham A, RulandJ, YoshidaH, Liu D, Elledge SJ and Mak TW: DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 287: 1824-1827, 2000.
3. Huang CL, Yokomise H and Miyatake A: Clinical significance of the p53 pathway and associated gene therapy in non-small cell lung cancers. Future Oncol 3: 83-93, 2007.
4. Kandioler D, Stamatis G, Eberhardt W, Kappel S, Zöchbauer-Müller S, Kührer I, Mittlböck M, Zwrtek R, AignerC, Bichler C, et al:. Growing clinical evidence for the interaction of the p53 genotype and response to induction chemotherapy in advanced non-small cell lung cancer. J Thorac Cardiovasc Surg135: 1036-1041, 2008.
5. Kandioler D, Zwrtek R, Ludwig C, Janschek E, Ploner M, Hofbauer F, Kührer I, Kappel S, Wrba F, Horvath M, et al: TP53 genotype but not p53 immunohistochemical result predicts response to preoperative short-term radiotherapy in rectal cancer. Ann Surg 235: 493-498, 2002.
6. Shiomitsu K, Sajo E, Xia X, Hunley DW, Mauldin GE, Li S and Mauldin GN: Radiosensitivity of canine osteosarcoma cells transfected with wild-type p53 in vitro. Vet Comp Oncol 6: 193-200, 2008.
7. Gudkov AV and Komarova EA: The role of p53 in determining sensitivity to radiotherapy. Nat Rev Cancer 3: 117-129, 2003.
8. Cuddihy AR and Bristow RG: The p53 protein family and radiation sensitivity: yes or no? Cancer Metastasis Rev 23: 237-257, 2004.
9. Takahashi T, Fukawa T, Hirayama R, Yoshida Y, Musha A, Furusawa Y, Ando K and Nakano T: In vitro interaction of high-LET heavy-ion irradiation and chemotherapeutic agents in two cell lines with different radiosensitivities and different p53 status. Anticancer Res 30: 1961-1967, 2010.
10. Takahashi A, Matsumoto H, Yuki K, Yasumoto J, KajiwaraA, Aoki M, Furusawa Y, Ohnishi K and Ohnishi T: High-LET radiation enhanced apoptosis but not necrosis regardless of p53 status. Int J Radiat Oncol Biol Phys 60: 591-597, 2004.
11. Pan JJ, Zhang SW, Chen CB, Xiao SW, Sun Y, Liu CQ, SuX, LiDM, Xu G, Xu B and Lu YY: Effect of recombinant adenovirus-p53 combined with radiotherapy on long-term prognosis of advanced nasopharyngeal carcinoma. J Clin Oncol27: 799-804, 2009.
12. Roth JA: Adenovirus p53 gene therapy. Expert Opin Biol Ther 6: 55-61, 2006.
13. Ma JT, Zheng W and Zou HW: Radiosensitivity enhanced by recombinant adenovirus p53 in lung adenocarcinoma. Journal of China Medical University 36: 424-426, 2007.
14. Ma G, Kawamura K, Li Q, Suzuki N, Liang M, Namba M, Shimada H and Tagawa M: Cytotoxicity of adenoviruses expressing the wild-type p53 gene to esophageal carcinoma cells is linked with the CAR expression level and indirectly with the endogenous p53 status. Cancer Gene Ther 16: 832-840, 2009.
15. Ashcroft M, Kubbutat MH and Vousden KH: Regulation of p53 function and stability by phosphorylation. Mol Cell Biol 19: 1751-1758, 1999.
16. Reed M, Woelker B, Wang P, Wang Y, Anderson ME and TegtmeyerP: The C-terminal domain of p53 recognizes DNA damaged by ionizing radiation. Proc Natl Acad Sci USA 92: 9455-9459, 1995.
17. Lakin ND and Jackson SP: Regulation of p53 in response to DNA damage. Oncogene 18: 7644-7655, 1999.
18. Gudkov AV and Komarova EA: Prospective therapeutic applications of p53 inhibitors. Biochem Biophys Res Commun 331: 726-736, 2005.